News
Self-help cognitive behavioral therapy for irritable bowel syndrome was successfully delivered via mobile application.
Sodium-glucose cotransporter 2 inhibitor use is an independent risk factor for falls in people with type 2 diabetes ...
US health officials directed food companies to voluntarily phase out petroleum-based synthetic dyes by the end of 2026. HealthDay News — The push to remove artificial colors from U.S. foods is gaining ...
Proportion of adult managed care organizations with access to cardioprotective medications varied from 24 to 100% for SGLT2 inhibitors and 0 to 99% for GLP-1 receptor agonists. HealthDay News — Many ...
A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...
Topline data were announced from two phase 3 studies evaluating tegoprazan in patients with gastroesophageal reflux disease (GERD).
The HHS said it won't slash funding for the Women's Health Initiative, a major research project focused on preventing disease in older women.
The likelihood of HCV clearance was increased by participation in Ryan White services among patients with HIV coinfection.
Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results